CorConsult Rx: Evidence-Based Medicine and Pharmacy
Health & Fitness:Medicine
On this episode, we review the data for tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the treatment of type 2 diabetes a new medication that is being investigated. We discuss the unique mechanism of action and summarize the data from the SURPASS studies.
Thanks for listening!
If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:
www.patreon.com/corconsultrx
If you have any questions for Cole or me, reach out to us on any of the following:
Text - 415-943-6116
Mike - mcorvino@corconsultrx.com
Cole - cswanson@corconsultrx.com
Instagram and other social media platforms - @corconsultrx
This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.
Dry Eye Disease
Dermatophyte Infections *ACPE-Accredited*
Patient Case: Newly Diagnosed DM2 and a History of CVA
Managing Crohn's Disease *ACPE-Accredited*
Medication Safety in Special Populations *ACPE-Accredited*
Interstitial Cystitis/ Bladder Pain Syndrome
The Basics of Treating Hepatitis C
A Review of SSRIs and the ANTLER Trial
Endometriosis
2021 C. difficile Treatment Guidelines
2021 Surviving Sepsis Guidelines
Updates in Migraine Pharmacotherapy *ACPE-Accredited*
New Data in HFpEF
Parkinson's Disease
Weight Loss Pharmacotherapy
Menopausal Hormone Therapy
Rheumatoid Arthritis
Patient Case: HFpEF, DM2, CKD, BPH
Food Allergies
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive